Ibrexafungerp is a triterpenoid antifungal compound that functions as a glucan synthase inhibitor. It is used in pharmaceutical manufacturing as an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ibrexafungerp?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ibrexafungerp citrate hydrate
pharmaceutical raw material
Cibinetide
pharmaceutical raw material
(S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic acid
pharmaceutical raw material
Oclacitinib
active pharmaceutical ingredient for veterinary use
Oclacitinib maleate
pharmaceutical raw material
The international HS code for Ibrexafungerp (CAS 1207753-03-4) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid
BODYFEUFKHPRCK-ZCZMVWJSSA-N
C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C
Sourcing Ibrexafungerp?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.